Pfizer Inc.
PFEDividend Contender • 16yrsAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Pfizer Inc. (PFE) operates in the Drug Manufacturers - General industry and is based in the United States. It pays a quarterly dividend of $1.75 a year, a yield of 5.81% at the current price of $30.03. Pfizer has raised its dividend for 16 consecutive years, which makes it a Dividend Contender. Over the last five years the dividend has grown by an average of 3.6% a year. It paid out 226% of its earnings as dividends, more than it earned. 28 analysts cover it; their average 12-month price target of $29.26 is 2.6% below the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.